指南与共识心脑血管急症重症综合管理与镇静镇痛

脑出血、蛛网膜下腔出血或急性缺血性卒中患者的目标温度管理:神经保护治疗共识审查(NTCR)小组更新的共识指南推荐

Targeted temperature management in patients with intracerebral haemorrhage, subarachnoid haemorrhage, or acute ischaemic stroke: updated consensus guideline recommendations by the Neuroprotective Therapy Consensus Review (NTCR) group.
指南 / 共识 · Br J Anaesth · 2023-05-22
一句话结论NTCR共识推荐:脑出血、动脉瘤性蛛网膜下腔出血或急性缺血性卒中需重症监护的患者,核心体温应持续监测并维持36.0°C至37.5°C,首次发热识别后1小时内启动目标温度管理。

该共识由神经保护治疗共识审查(NTCR)小组采用改良德尔菲法制定,纳入19名国际神经重症专家,所有声明共识阈值设为≥80%。推荐对脑出血、动脉瘤性蛛网膜下腔出血和急性缺血性卒中需入住重症监护的患者,尽可能使用自动反馈控制装置持续监测核心体温并维持在36.0°C至37.5°C;首次发热识别后1小时内启动目标温度管理,同时适当诊断和治疗感染,维持至大脑仍处于继发性损伤风险期间,并控制复温。应监测和管理寒战以限制继发性损伤风险,并希望在这三种疾病中采用统一的目标温度管理方案。

要点

  • 脑出血、动脉瘤性蛛网膜下腔出血或急性缺血性卒中需重症监护者,核心体温应持续监测并维持36.0°C至37.5°C。
  • 尽可能使用自动反馈控制装置进行体温管理。
  • 首次发热识别后1小时内启动目标温度管理,并适当诊断和治疗感染。
  • 目标温度管理维持至大脑仍处于继发性损伤风险期间,复温应受控制。
  • 应监测和管理寒战以限制继发性损伤风险;希望三种疾病采用统一的目标温度管理方案。

适用人群与场景

  • 脑出血、动脉瘤性蛛网膜下腔出血或急性缺血性卒中后需要入住重症监护的患者。

诊断标准与关键阈值

  • 核心体温目标范围:36.0°C至37.5°C。
  • 首次发热识别后1小时内启动目标温度管理。
  • 所有声明共识阈值:≥80%。

处置流程与药物剂量

  • 核心体温应理想地持续监测,并尽可能使用自动反馈控制装置维持在36.0°C至37.5°C。
  • 目标温度管理应在首次发热识别后1小时内启动,同时适当诊断和治疗感染。
  • 目标温度管理应维持至大脑仍处于继发性损伤风险期间,复温应受控制。
  • 应监测和管理寒战以限制继发性损伤风险。
  • 希望脑出血、动脉瘤性蛛网膜下腔出血和急性缺血性卒中采用统一的目标温度管理方案。

研究设计与关键结果

  • 采用改良德尔菲共识法,神经保护治疗共识审查(NTCR)小组纳入19名国际神经重症监护专家,所有声明共识阈值设为≥80%。
  • 推荐基于现有证据、文献回顾和共识制定。

证据类型、等级与局限

  • 证据类型:改良德尔菲专家共识指南。
  • 共识阈值:所有声明≥80%。
  • 局限:原文指出需要进一步研究以改进该领域的临床指南。

对床旁实践的改变

  • 对脑出血、动脉瘤性蛛网膜下腔出血或急性缺血性卒中需重症监护的患者,应持续监测核心体温并尽可能用自动反馈控制装置维持在36.0°C至37.5°C。
  • 首次发热识别后1小时内启动目标温度管理,同时适当诊断和治疗感染,维持至大脑仍处于继发性损伤风险期间,并控制复温。
  • 应监测和管理寒战以限制继发性损伤风险;希望三种疾病采用统一的目标温度管理方案。

指南或共识出处

  • 神经保护治疗共识审查(NTCR)小组更新的共识指南推荐,发表于Br J Anaesth。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is a lack of consistent, evidence-based guidelines for the management of patients with fever after brain injury. The aim was to update previously published consensus recommendations on targeted temperature management after intracerebral haemorrhage, aneurysmal subarachnoid haemorrhage, and acute ischaemic stroke in patients who require admission to critical care.

METHODS: A modified Delphi consensus, the Neuroprotective Therapy Consensus Review (NTCR), included 19 international neuro-intensive care experts with a subspecialty interest in the acute management of intracerebral haemorrhage, aneurysmal subarachnoid haemorrhage, and acute ischaemic stroke. An online, anonymised survey was completed ahead of the meeting before the group came together to consolidate consensus and finalise recommendations on targeted temperature management. A threshold of ≥80% for consensus was set for all statements.

RESULTS: Recommendations were formulated based on existing evidence, literature review, and consensus. After intracerebral haemorrhage, aneurysmal subarachnoid haemorrhage, and acute ischaemic stroke in patients who require critical care admission, core temperature should ideally be monitored continuously and maintained between 36.0°C and 37.5°C using automated feedback-controlled devices, where possible. Targeted temperature management should be commenced within 1 h of first fever identification with appropriate diagnosis and treatment of infection, maintained for as long as the brain remains at risk of secondary injury, and rewarming should be controlled. Shivering should be monitored and managed to limit risk of secondary injury. Following a single protocol for targeted temperature management across intracerebral haemorrhage, aneurysmal subarachnoid haemorrhage, and acute ischaemic stroke is desirable.

CONCLUSIONS: Based on a modified Delphi expert consensus process, these guidelines aim to improve the quality of targeted temperature management for patients after intracerebral haemorrhage, aneurysmal subarachnoid haemorrhage, and acute ischaemic stroke in critical care, highlighting the need for further research to improve clinical guidelines in this setting.

来源:Br J Anaesth,查看原文。版权归原作者所有。

参考来源

  1. Lavinio A, Andrzejowski J, Antonopoulou I, et al. Targeted temperature management in patients with intracerebral haemorrhage, subarachnoid haemorrhage, or acute ischaemic stroke: updated consensus guideline recommendations by the Neuroprotective Therapy Consensus Review (NTCR) group. Br J Anaesth. 2023. PMID: 37225535. doi:10.1016/j.bja.2023.04.030

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。